<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-FERSHNKX</identifier><date>2023</date><creator>Petre, Maja</creator><relation>documents/doc/F/URN_NBN_SI_doc-FERSHNKX_001.pdf</relation><relation>documents/doc/F/URN_NBN_SI_doc-FERSHNKX_001.txt</relation><format format_type="issue">2</format><format format_type="volume">74</format><format format_type="type">article</format><format format_type="extent">str. 108-114</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">157978883</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-FERSHNKX</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antidepresivi</subject><subject language_type_id="eng">antidepressants</subject><subject language_type_id="eng">discontinuation</subject><subject language_type_id="slv">odtegnitveni sindromi</subject><subject language_type_id="slv">povratni učinki</subject><subject language_type_id="eng">rebound effects</subject><subject language_type_id="slv">ukinjanje</subject><subject language_type_id="eng">withdrawal symptoms</subject><title>Odtegnitveni simptomi ob prenehanju jemanja antidepresivov</title><title>Withdrawal symptoms following discontinuation of antidepressants</title></Record>